Novo Nordisk A/S (NYSE:NVO) is one of the best beginner stocks to buy, according to analysts. On September 17, Berenberg upgraded Novo Nordisk from ‘Hold’ to ‘Buy’, and revised its price target to DKK425.00, signaling a potential 20% upside. Berenberg Upgrades Novo Nordisk (NVO) Amid Renewed Growth Outlook Pixabay/Public Domain The move comes after a series of guidance downgrades that followed the company’s mid-2024 share price peak, prompting a reset in market expectations. Berenberg believes this shif ...